Expands Xtant’s Product Offering with the Leading PMA-Approved Intralaminar Stabilization Device Strengthens Surgalign’s Balance Sheet as it Embarks on its Digital Health Strategy BELGRADE, Mont. and DEERFIELD, Ill. , March 01, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc.